Schedules of Controlled Substances: DEA Scheduling of Benzodiazepine Analogs in 2026
Comments Off on Schedules of Controlled Substances: DEA Scheduling of Benzodiazepine Analogs in 2026
April 11, 2026
The DEA scheduling benzodiazepine analogs 2026 update places five synthetic benzodiazepines into Schedule I, addressing significant regulatory gaps. This action impacts clinical management and toxicology screening. Awareness of these changes is crucial…
MCRGC, LLC: Federal Decision and Order Overview
This page covers the federal cannabis manufacturing decision regarding MCRGC LLC. The decision and order affect regulatory compliance and patient access to medical cannabis. Understanding this federal action is key for stakeholders in cannabis…
CED Regulatory Digest, Since Last Digest, 2 items
Digest covering 2 recent regulatory items.
CED Regulatory Digest, Since Last Digest, 1 items
Comments Off on CED Regulatory Digest, Since Last Digest, 1 items
March 21, 2026
Digest covering 1 recent regulatory items.